Silva Pharmaceuticals Statistics

Total Valuation

Silva Pharmaceuticals has a market cap or net worth of BDT 1.42 billion. The enterprise value is 1.29 billion.

Market Cap	1.42B
Enterprise Value	1.29B

Important Dates

The last earnings date was Thursday, October 24, 2024.

Earnings Date	Oct 24, 2024
Ex-Dividend Date	Dec 2, 2024

Share Statistics

Silva Pharmaceuticals has 136.50 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	136.50M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	30.52%
Owned by Institutions (%)	n/a
Float	66.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.32
PB Ratio	0.61
P/TBV Ratio	n/a
P/FCF Ratio	121.37
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 36.09, with an EV/FCF ratio of 110.11.

EV / Earnings	-41.66
EV / Sales	2.11
EV / EBITDA	36.09
EV / EBIT	n/a
EV / FCF	110.11

Financial Position

The company has a current ratio of 13.23, with a Debt / Equity ratio of 0.02.

Current Ratio	13.23
Quick Ratio	5.69
Debt / Equity	0.02
Debt / EBITDA	1.31
Debt / FCF	4.00
Interest Coverage	-6.56

Financial Efficiency

Return on equity (ROE) is -1.33% and return on invested capital (ROIC) is -0.65%.

Return on Equity (ROE)	-1.33%
Return on Assets (ROA)	-0.62%
Return on Capital (ROIC)	-0.65%
Revenue Per Employee	799,498
Profits Per Employee	-40,409
Employee Count	587
Asset Turnover	0.24
Inventory Turnover	0.92

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -51.85% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-51.85%
50-Day Moving Average	11.82
200-Day Moving Average	15.31
Relative Strength Index (RSI)	45.71
Average Volume (20 Days)	231,910

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Silva Pharmaceuticals had revenue of BDT 611.62 million and -30.91 million in losses. Loss per share was -0.23.

Revenue	611.62M
Gross Profit	173.70M
Operating Income	-24.95M
Pretax Income	-23.50M
Net Income	-30.91M
EBITDA	32.26M
EBIT	-24.95M
Loss Per Share	-0.23

Full Income Statement

Balance Sheet

The company has 178.53 million in cash and 46.83 million in debt, giving a net cash position of 131.70 million or 0.96 per share.

Cash & Cash Equivalents	178.53M
Total Debt	46.83M
Net Cash	131.70M
Net Cash Per Share	0.96
Equity (Book Value)	2.31B
Book Value Per Share	16.92
Working Capital	926.86M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -16.66 million and capital expenditures 28.36 million, giving a free cash flow of 11.70 million.

Operating Cash Flow	-16.66M
Capital Expenditures	28.36M
Free Cash Flow	11.70M
FCF Per Share	0.09

Full Cash Flow Statement

Margins

Gross margin is 28.40%, with operating and profit margins of -4.08% and -5.05%.

Gross Margin	28.40%
Operating Margin	-4.08%
Pretax Margin	-3.84%
Profit Margin	-5.05%
EBITDA Margin	5.27%
EBIT Margin	-4.08%
FCF Margin	1.91%

Dividends & Yields

This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.96%.

Dividend Per Share	0.10
Dividend Yield	0.96%
Dividend Growth (YoY)	-66.67%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	0.96%
Earnings Yield	-2.18%
FCF Yield	0.82%

Dividend Details

Stock Splits

The last stock split was on November 7, 2019. It was a forward split with a ratio of 1.05.

Last Split Date	Nov 7, 2019
Split Type	Forward
Split Ratio	1.05

Scores

Silva Pharmaceuticals has an Altman Z-Score of 11.92.

Altman Z-Score	11.92
Piotroski F-Score	n/a